Harry J Leonhardt - Net Worth and Insider Trading
Harry J Leonhardt Net Worth
The estimated net worth of Harry J Leonhardt is at least $72,916 dollars as of 2024-09-20. Harry J Leonhardt is the SVP, Gen.Counsel & Corp. Sec. of Senomyx Inc and owns about 48,937 shares of Senomyx Inc (SNMX) stock worth over $72,916. Details can be seen in Harry J Leonhardt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harry J Leonhardt has not made any transactions after 2007-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Harry J Leonhardt
Harry J Leonhardt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harry J Leonhardt owns 3 companies in total, including Poseida Therapeutics Inc (PSTX) , Halozyme Therapeutics Inc (HALO) , and Senomyx Inc (SNMX) .
Click here to see the complete history of Harry J Leonhardt’s form 4 insider trades.
Insider Ownership Summary of Harry J Leonhardt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2020-09-15 | GC & Chief Compliance Officer |
| HALO | Halozyme Therapeutics Inc | 2016-02-03 | SVP & GC and CCO |
| SNMX | Senomyx Inc | 2007-09-04 | SVP & Gen.Counsel & Corp. Sec. |
Harry J Leonhardt Latest Holdings Summary
Harry J Leonhardt currently owns a total of 1 stock. Harry J Leonhardt owns 48,937 shares of Senomyx Inc (SNMX) as of September 4, 2007, with a value of $72,916.
Latest Holdings of Harry J Leonhardt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNMX | Senomyx Inc | 2007-09-04 | 48,937 | 1.49 | 72,916 |
Holding Weightings of Harry J Leonhardt
Harry J Leonhardt Form 4 Trading Tracker
According to the SEC Form 4 filings, Harry J Leonhardt has made a total of 0 transactions in Senomyx Inc (SNMX) over the past 5 years. The most-recent trade in Senomyx Inc is the sale of 228 shares on September 4, 2007, which brought Harry J Leonhardt around $3,021.
Insider Trading History of Harry J Leonhardt
- 1
Harry J Leonhardt Trading Performance
Harry J Leonhardt Ownership Network
Harry J Leonhardt Owned Company Details
What does Poseida Therapeutics Inc do?
Who are the key executives at Poseida Therapeutics Inc?
Harry J Leonhardt is the GC & Chief Compliance Officer of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .
Poseida Therapeutics Inc (PSTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Poseida Therapeutics Inc Insider Transactions
Harry J Leonhardt Mailing Address
Above is the net worth, insider trading, and ownership report for Harry J Leonhardt. You might contact Harry J Leonhardt via mailing address: C/o Halozyme Therapeutics, Inc., 11388 Sorrento Valley Blvd., San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
